Chinese Biosimilars Go Global: From Domestic Success to International Competition
For years, China was known primarily as a manufacturer of generic medicines and active pharmaceutical ingredients (APIs). Today, a new generation of Chinese biopharmaceutical companies is moving into one of the pharmaceutical industry’s most demanding markets: biosimilars. Their ambitions extend far beyond China. Companies are securing approvals in Europe, the United States, Canada, and emerging […]
